415 Capital
415 CAPITAL is a specialist venture capital firm that invests in early- and development-stage MedTech companies in Europe, the United States and Israel.
We primarily invest in innovative medical device technologies addressing cardiovascular disease: the worldwide leading cause of death and the single largest cost driver in the global healthcare system.
We are investors AND entrepreneurs: As investors, we have funded 45 MedTech companies in the past 28 years. As entrepreneurs, we have founded, built, and exited several successful European MedTech distribution companies.